1. Home
  2. PDSB vs WYY Comparison

PDSB vs WYY Comparison

Compare PDSB & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • WYY
  • Stock Information
  • Founded
  • PDSB 2005
  • WYY 1991
  • Country
  • PDSB United States
  • WYY United States
  • Employees
  • PDSB N/A
  • WYY N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • WYY EDP Services
  • Sector
  • PDSB Health Care
  • WYY Technology
  • Exchange
  • PDSB Nasdaq
  • WYY Nasdaq
  • Market Cap
  • PDSB 44.5M
  • WYY 48.9M
  • IPO Year
  • PDSB N/A
  • WYY 1998
  • Fundamental
  • Price
  • PDSB $0.94
  • WYY $6.87
  • Analyst Decision
  • PDSB Strong Buy
  • WYY Strong Buy
  • Analyst Count
  • PDSB 2
  • WYY 3
  • Target Price
  • PDSB $10.00
  • WYY $8.00
  • AVG Volume (30 Days)
  • PDSB 489.6K
  • WYY 61.1K
  • Earning Date
  • PDSB 11-13-2025
  • WYY 11-12-2025
  • Dividend Yield
  • PDSB N/A
  • WYY N/A
  • EPS Growth
  • PDSB N/A
  • WYY N/A
  • EPS
  • PDSB N/A
  • WYY N/A
  • Revenue
  • PDSB N/A
  • WYY $144,421,640.00
  • Revenue This Year
  • PDSB N/A
  • WYY $9.19
  • Revenue Next Year
  • PDSB N/A
  • WYY $13.16
  • P/E Ratio
  • PDSB N/A
  • WYY N/A
  • Revenue Growth
  • PDSB N/A
  • WYY 16.25
  • 52 Week Low
  • PDSB $0.85
  • WYY $2.19
  • 52 Week High
  • PDSB $3.48
  • WYY $6.74
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 40.57
  • WYY 75.73
  • Support Level
  • PDSB $0.89
  • WYY $5.25
  • Resistance Level
  • PDSB $1.03
  • WYY $6.74
  • Average True Range (ATR)
  • PDSB 0.06
  • WYY 0.31
  • MACD
  • PDSB 0.00
  • WYY 0.10
  • Stochastic Oscillator
  • PDSB 31.67
  • WYY 100.00

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: